Critics Question World Health Organization's Stance on E-cigarettes

Regulations by 2FIRSTS.ai
Apr.10.2024
Critics Question World Health Organization's Stance on E-cigarettes
World Health Organization's statement on e-cigarette-induced seizures sparks controversy on social media, prompting fact-checking and debate.

According to a report by the Daily Mail, the World Health Organization recently made a statement on the social platform "X", claiming that e-cigarettes can cause seizures within a few hours, which has sparked criticism from various parties. The global health organization's statement on "X" was fact-checked by internet users, and the social platform later released a community statement.

 

Critics Question World Health Organization's Stance on E-cigarettes
Translate to English: WHO post | Image source: X

 

The announcement stated: "The basis of this post is research that has not been peer-reviewed and the evidence is uncertain. The basis of this statement is approximately 120 uncertain events that have occurred since 2019."

 

Dr. Charles Gardner, a developmental neurobiologist in Brooklyn, tweeted, "Please provide peer-reviewed evidence to support the claim that e-cigarettes 'typically' trigger seizures within 24 hours. If you cannot do this, please delete your tweet. Note: I have reviewed the literature and have not found any studies showing that e-cigarettes increase the risk of seizures.

 

In addition, some users have referred to the World Health Organization as clowns and liars, claiming that they are spreading propaganda. Steve Rolles, senior policy analyst at the Transform Drug Policy Foundation, also said, "I am convinced this is nonsense. Why is the World Health Organization's stance on e-cigarettes so peculiarly out of line?"

 

Critics Question World Health Organization's Stance on E-cigarettes
Supplementary statement of the WHO post | Image source: X

 

In a community announcement on "X," a link to an editorial on e-cigarettes and epilepsy was included. The editorial, published in the Journal of Adolescent Health, discusses a 2019 study analyzing 122 cases of seizure and other neurological symptoms in individuals who reported using e-cigarettes in the past 24 hours. Due to its potential to trigger seizures, researchers suggest that participants may be at risk for nicotine-induced epilepsy and symptoms.

 

However, the editorial pointed out that the details of the study "raise questions about causality, which must be considered when assessing the actual health risks of nicotine e-cigarettes for adolescents." It also noted, "A major question is why inhaling nicotine from e-cigarettes can trigger seizures, while inhaling nicotine from traditional tobacco does not.

 

The authors point out that a person would need to inhale a large dose of nicotine to trigger a seizure, but e-cigarette devices contain much lower levels of nicotine compared to traditional cigarettes. Additionally, the toxic effects of high doses of nicotine are expected to appear within minutes of inhalation and dissipate within a few hours. The authors state, "Seizures do not seem likely to occur if there are no other systemic toxic effects present.

 

In the United States, the use of e-cigarettes has reached record levels, with over 17 million adults and 2 million children addicted to these devices. An editorial pointed out a flaw in a 2019 study, stating that the analysis of reported seizures was based on self-reporting and not always clear. Descriptions varied, with some individuals reporting severe seizures while others detailed tremors or seizure-like activity. In most cases, these events were not evaluated by medical professionals. The editorial's author noted that nicotine could potentially cause anxiety attacks and unconscious muscle contractions, leading some individuals to misinterpret these symptoms as seizures, even though they are not.

 

Despite traditional cigarette smoking rates decreasing each year, the number of people using e-cigarettes is continuously increasing, especially among middle and high school students. An analysis from the Centers for Disease Control and Prevention (CDC) in 2023 found that 2.1 million children, or nearly 8% of the student population, are using these devices, with 47% of children who have tried e-cigarettes still currently using them.

 

E-cigarettes typically come in attractive flavors such as cotton candy and caramel custard, and their packaging designs appeal to younger users. Data shows that approximately 90% of young people report having used products with fruit or candy flavors.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Ahead of implementation, DOJO, PIXL and Hayati have introduced or been reported to be adding lower-capacity tiers alongside larger products. DOJO has added a 6ml BLAST7K Fresh below its 10ml BLAST10K Fresh, PIXL offers both a 12ml 8000 and a 6ml 5K, while retailer Ninja Vapes says Hayati is preparing a 7ml 4K alongside its existing 12ml 6K. The pattern points to a growing lower-capacity tier in the UK market, although the brands have not all explicitly linked the changes to the new duty.
Sep.23
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania begins enforcing its electronic nicotine delivery system (ENDS) directory restrictions on October 19, 2026. The October 18 directory contained 163 product records from seven manufacturers, including Vuse, JUUL, NJOY, Logic and Naked 100. Geek Bar, RAZ and Lost Mary were absent. BAT, Altria, Japan Tobacco and JUUL collectively accounted for 112 records, or 68.7%, while Imperial Brands' blu had no listings. The directory included 15 disposable vape records, 40 bottled e-liquids and 10 products labeled 0mg, but no open-system refillable devices. Twenty-two manufacturer certifications remained under review. Four Logic models corresponding to Smoore's pending records were listed under the brand owner, while LYCO, OXBAR and Boulder/Rock had no approved directory entries.
Regulations
Oct.19
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives